Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib ; volume:9 ; number:1 ; day:18 ; month:2 ; year:2019 ; pages:1-7 ; date:12.2019
Scientific reports ; 9, Heft 1 (18.2.2019), 1-7, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Nannini, Margherita
Tarantino, Giuseppe
Indio, Valentina
Ravegnini, Gloria
Astolfi, Annalisa
Urbini, Milena
De Leo, Antonio
Santini, Donatella
Ceccarelli, Claudio
Gruppioni, Elisa
Altimari, Annalisa
Castellucci, Paolo
Fanti, Stefano
Di Scioscio, Valerio
Saponara, Maristella
Gatto, Lidia
Pession, Andrea
Martelli, Pier Luigi
Casadio, Rita
Pantaleo, Maria Abbondanza
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-38028-x
- URN
-
urn:nbn:de:101:1-2019031419362845971230
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nannini, Margherita
- Tarantino, Giuseppe
- Indio, Valentina
- Ravegnini, Gloria
- Astolfi, Annalisa
- Urbini, Milena
- De Leo, Antonio
- Santini, Donatella
- Ceccarelli, Claudio
- Gruppioni, Elisa
- Altimari, Annalisa
- Castellucci, Paolo
- Fanti, Stefano
- Di Scioscio, Valerio
- Saponara, Maristella
- Gatto, Lidia
- Pession, Andrea
- Martelli, Pier Luigi
- Casadio, Rita
- Pantaleo, Maria Abbondanza
- SpringerLink (Online service)
Ähnliche Objekte (12)
Reintroduction of Imatinib in GIST
KIT exon 11 and PDGFRA exon 18 gene mutations in gastric GIST: proposal of a short panel for predicting therapeutic response
Succinate dehydrogenase deficiency in a PDGFRA mutated GIST
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)
Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST Patients
Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung
Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics
Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib
Reintroduction of Imatinib in GIST
KIT exon 11 and PDGFRA exon 18 gene mutations in gastric GIST: proposal of a short panel for predicting therapeutic response
Succinate dehydrogenase deficiency in a PDGFRA mutated GIST
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)
Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST Patients
Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung
Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics
Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib
Reintroduction of Imatinib in GIST
KIT exon 11 and PDGFRA exon 18 gene mutations in gastric GIST: proposal of a short panel for predicting therapeutic response
Succinate dehydrogenase deficiency in a PDGFRA mutated GIST
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)
Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST Patients
Gastrointestinale Stromatumoren (GIST) : Imatinib-Therapieoptionen voll ausschöpfen durch Dosisoptimierung
Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics
Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)